NSYNC's Lance Bass Reveals Daily Struggles Managing Type 1.5 Diabetes

NSYNC's Lance Bass Reveals Daily Struggles Managing Type 1.5 Diabetes

By Dr. Marcus Chen, Ph.D.

February 14, 2025 at 09:53 PM

Lance Bass, former NSYNC member, recently revealed his journey with type 1.5 diabetes (LADA) after an initial misdiagnosis of type 2 diabetes.

image

image

Type 1.5 diabetes, or latent autoimmune diabetes in adults (LADA), is diagnosed in adults over 30 and progresses more slowly than type 1 diabetes. It's often misdiagnosed as type 2 due to similar onset patterns.

Key differences between diabetes types:

  • Type 1: Immediate insulin dependency
  • Type 1.5 (LADA): Initially responds to oral medications before requiring insulin
  • Type 2: Focuses on lifestyle changes and oral medications

Bass's Experience and Management:

  • Discovered through routine blood work after unsuccessful type 2 treatments
  • Uses Dexcom G7 continuous glucose monitor
  • Manages symptoms through:
    • Regular hydration
    • High-fiber diet
    • Exercise, particularly weight training
    • Proper insulin management

Treatment Approach:

  • Insulin dependency
  • Experimental stem cell treatment (90 million cells)
  • Continuous glucose monitoring
  • Lifestyle modifications

Impact on Daily Life:

  • Requires constant monitoring and planning
  • Affects energy levels and physical capability
  • Demands medication management and temperature control
  • Partner support crucial for management

His message emphasizes education and awareness, particularly for young people with diabetes. Bass actively shares his experience to help others navigate their diagnosis and treatment journey.

Medical Management Tips:

  • Regular blood sugar monitoring
  • Proper insulin dosing and timing
  • Maintaining medication schedules
  • Regular exercise
  • Balanced diet
  • Adequate hydration

While type 1.5 diabetes requires careful management, proper diagnosis and treatment can lead to effective symptom control. Currently, stem cell treatments remain experimental and aren't FDA-approved for LADA.

Consult healthcare providers for proper diagnosis and treatment planning, as management needs vary by individual.

Related Articles

Previous Articles